文献速递胃肠外科围术期管理与 ERAS

术前改良衰弱指数高对腹腔镜胃癌根治术后八旬患者短期和长期结局有负面影响

High preoperative modified frailty index has a negative impact on short- and long-term outcomes of octogenarians with gastric cancer after laparoscopic gastrectomy.
PubMed 文献 · Surg Endosc · 2018-02-08

本研究回顾性分析了2007年至2012年间119例80岁及以上接受腹腔镜胃癌根治术的患者,依据术前白蛋白<3.4 g/dL、血细胞比容<35%、肌酐>2 mg/dL三项指标计算术前改良衰弱指数(PMFI),分为高PMFI(3项)和低PMFI(0-2项)。结果显示高PMFI与术后并发症风险增加相关(OR 2.506,95%CI 1.113-5.643,P=0.027),且3年总生存率和无复发生存率显著更低,但癌症特异性生存率无差异。

要点

  • 高PMFI(3项指标均阳性)与术后并发症风险增加独立相关。
  • 高PMFI组3年总生存率和无复发生存率显著低于低PMFI组。
  • PMFI基于常规术前实验室指标,可作为低成本筛查工具。

核心结论

  • 基于易计算的术前指标的高PMFI可能有助于预测术后并发症,并对八旬患者腹腔镜胃癌根治术后的3年总生存率和无复发生存率有负面影响。

研究设计与样本

  • 回顾性分析2007年1月至2012年12月前瞻性收集的119例80岁及以上接受腹腔镜胃癌根治术的胃癌患者数据。

主要发现

  • 43例(36.1%)为高PMFI,76例(63.9%)为低PMFI。
  • 高PMFI与术后并发症风险增加相关(OR 2.506;95%CI 1.113-5.643,P=0.027)。
  • 中位随访39.0个月,全队列3年总生存率、无复发生存率和癌症特异性生存率分别为47.9%、34.3%和51.7%。
  • 高PMFI组与低PMFI组3年总生存率分别为37.2%和53.9%(P=0.038),无复发生存率分别为23.3%和40.5%(P=0.012)。
  • 两组3年癌症特异性生存率分别为43.5%和56.4%(P=0.078),无显著差异。

关键数值与推荐

  • 术前改良衰弱指数(PMFI)基于三项指标:白蛋白<3.4 g/dL、血细胞比容<35%、肌酐>2 mg/dL。
  • 高PMFI定义为3项指标均阳性,低PMFI定义为0-2项阳性。

临床怎么用

  • 对于八旬胃癌患者,术前可通过常规实验室指标计算PMFI,识别高PMFI个体以预警术后并发症风险和不良长期生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The proportion of elderly patients who undergo surgery has rapidly increased. However, clinical indicators that predict outcomes are limited. Frailty is thought to estimate physiological reserves, although its use has not been evaluated in laparoscopic surgical patients. This study aimed to evaluate the significance of preoperative modified frailty index (PMFI) in octogenarians undergoing a laparoscopic gastrectomy. METHODS: We reviewed prospectively collected data from 119 patients with gastric cancer (GC) aged 80 years or older who underwent a radical laparoscopic gastrectomy (RLG) between January 2007 and December 2012. Three baseline frailty traits were measured using routine preoperative laboratory data: albumin < 3.4 g/dL, haematocrit < 35%, and creatinine > 2 mg/dL. Patients were categorized by the number of positive traits as follows: low preoperative modified frailty index (LPMFI): 0-2 traits and high preoperative modified frailty index (HPMFI): 3 traits. We compared patient characteristics, operative outcomes, pathological results, morbidity, and survival. RESULTS: A total of 43 (36.1%) patients were considered HPMFI, and 76 (63.9%) patients were considered LPMFI. HPMFI was associated with an increased risk of postoperative complications (HPMFI group: odds ratio 2.506; 95% CI, 1.113-5.643, P = 0.027). With a median follow-up of 39.0 months, the 3-year overall survival (OS), recurrence-free survival (RFS), and cancer-specific survival (CSS) rates for the entire cohort were 47.9, 34.3, and 51.7%, respectively. Significant differences were observed in OS (HPMFI group, 37.2%; LPMFI group, 53.9%; P = 0.038) and RFS (HPMFI group, 23.3%; LPMFI group, 40.5%; P = 0.012) between the groups, but no difference was found for CSS (HPMFI group, 43.5%; LPMFI group, 56.4%; P = 0.078). CONCLUSIONS: HPMFI based on an easily calculable preoperative measure may be useful for predicting postoperative complications and have a negative impact on 3-year OS and RFS after an RLG in octogenarians. Therefore, HPMFI can serve as a low-cost, simple screen for high-risk individuals who might suffer more than expected during the postoperative period after an RLG.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lu J, Zheng HL, Li P, et al. High preoperative modified frailty index has a negative impact on short- and long-term outcomes of octogenarians with gastric cancer after laparoscopic gastrectomy. Surg Endosc. 2018. PMID: 29423551. doi:10.1007/s00464-018-6085-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。